Case Type: Mergers & Acquisitions

TuHURA Biosciences, Inc. (NASDAQ: HURA), relating to the proposed merger with Kineta, Inc. Under the terms of the agreement, TuHURA would acquire the rights to Kineta’s novel KVA12123 antibody for a combination of cash and shares of TuHURA common stock.

Kineta, Inc. (OTC: KANT), relating to the proposed merger with TuHURA Biosciences, Inc. Under the terms of the agreement, TuHURA would acquire the rights to Kineta’s novel KVA12123 antibody for a combination of cash and shares of TuHURA common stock.

Patterson Companies, Inc. (NASDAQ: PDCO), relating to the proposed merger with Patient Square Capital. Under the terms of the agreement, shareholders of Patterson will receive $31.35 in cash per share.

MoneyLion Inc. (NYSE: ML), relating to the proposed merger with Gen Digital Inc. Under the terms of the agreement, shareholders of MoneyLion will receive $82.00 per share in cash, and in addition, one contingent value right per share entitling the shareholder to a contingent payment of Gen Digital common stock.

Enterprise Bancorp, Inc. (NASDAQ: EBTC), relating to the proposed merger with Independent Bank Corp. Under the terms of the agreement, shareholders of Enterprise will receive 0.60 shares of Independent, and $2.00 in cash, per share held.

Omnicom Group Inc. (NYSE: OMC), relating to the proposed merger with The Interpublic Group of Companies, Inc. Under the terms of the agreement, Omnicom shareholders will own 60.6% of the combined company.

The Interpublic Group of Companies, Inc. (NYSE: IPG), relating to the proposed merger with Omnicom Group Inc. Under the terms of the agreement, Interpublic shareholders will own 39.4% of the combined company.

SK Growth Opportunities Corporation (NASDAQ: SKGR), relating to the proposed merger with Webull Corp. Under the terms of the agreement, shares of SK Growth will be converted into shares of Webull Corp.

Arcadia Biosciences, Inc. (NASDAQ: RKDA), relating to the proposed merger with Roosevelt Resources LP. Under the terms of the agreement, Roosevelt and Arcadia shareholders are expected to own approximately 90% and 10%, respectively, of the outstanding shares of Arcadia.

Cross Country Healthcare, Inc. (NASDAQ: CCRN), relating to the proposed merger with Aya Healthcare. Under the terms of the agreement, shares of Cross Country will be converted into the right to receive $18.61 in cash.